DUBLIN, May 16, 2023 /PRNewswire/ -- Alkermes plc (ALKS) (Nasdaq: ALKS) today announced the presentation of research related to its psychiatry portfolio—which includes LYBALVI ® (olanzapine and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results